BioStem Technologies
Manufacturing · Florida, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
4901 NW 17th Way Ste 606, Fort Lauderdal...Phone Number
(954) 380-8342Website
www.biostemtechnologies.comRevenue
$292.2 MillionStock Symbol
BSEMIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About BioStem Technologies
BioStem Technologies, Inc. is a global life sciences corporation, providing innovative technologies with a concentration in Regenerative Medicine. The company's mission is to discover, develop and produce the most effective Regenerative Medicine products in the world. BioStem Technologies offers a comprehensive portfolio of high-quality brands that include RHEO, VENDAJE, VENDAJE AC, and VENDAJE OPTIC. The company is comprised of a diverse group of scientists, physicians, and entrepreneurs who collaborate to create innovative products.Explore more
BioStem Technologies Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BioStem Technologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if BioStem Technologies is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at BioStem Technologies
Earning: See what the market has to say on BioStem Technologies recently announced quarterly report
BioStem Technologies, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if BioStem Technologies has recently received funding, and reach out quickly before it becomes old news!
Click to see if BioStem Technologies had a recent Job posting/layoffs
Product Launch: Get notified when BioStem Technologies launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once BioStem Technologies has new funding data
Recommended Actions
Find VP level buyers at BioStem Technologies
Find more new buyers
Compare Similar Companies to BioStem Technologies
Compare insights from companies similar to BioStem Technologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$15.6M
51-200
Private
<$5M
2010
Gabriel HyamsChairman and Majority Shareholder (2020-Present) Founder and President and CEO (2010-2020)
Company Profile Activity
Activity Insights
BioStem Technologies is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
BioStem Technologies is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BioStem Technologies.
BioStem Technologies financials insights
Gather financial insights about BioStem Technologies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$146K
2026
Stock/Share Issuance
$2.5M
Stock/Share Issuance
$40M
BioStem Technologies Tech Stack
A closer look at the technologies used by BioStem Technologies
See more technologies
Most Recent Scoops
Earnings
BioStem Technologies has reported Q2 2026 revenue of $7.9 million, compared to $11 million in Q2 2025, with the year-over-year decline attributable to a CMS pricing reset on the company's BioRetain wound care business, which was concentrated in physician office product-based reimbursement prior to the BioTissue acquisition.
Earnings, Acquisitions, Finance, Pricing
Earnings
BioStem Technologies has reported a GAAP net loss of $9 million, or $0.52 per share, for Q2 2026, compared with net income of $10,000, or $0.00 per share, in Q2 2025, with an adjusted EBITDA loss of $4.6 million versus adjusted EBITDA income of $2.5 million in Q2 2025.
Earnings, Finance
Earnings
BioStem Technologies has reported operating expenses of $13.2 million for Q2 2026, compared with $12.6 million in Q1 2026, with the sequential increase driven primarily by continued investment in the commercial organization and supporting infrastructure.
Earnings, Spending/Investment, Finance
Earnings
BioStem Technologies has reported gross profit of $4.8 million, representing a gross margin of 61%, for Q2 2026, compared with gross profit of $3.8 million and a gross margin of 61% in Q1 2026, with the company anticipating modest gross margin pressure in the second half of the year related to pre-existing NEOX and CLARIX inventory purchased at a discount to supply agreement pricing.
Earnings, Finance
Project
Spending/Investment, Finance, Financial Operations, Manufacturing Operations
BioStem Technologies News & Media
BioStem Technologies Secures Up To $40 Million Equity Facility From Roth Principal Investments
BioStem Technologies has secured access to up to $40 million through a committed equity facility with Roth Principal Investments, providing the regenerative medicine company with additional capital flexibility as it expands its commercial and clinical operations.BioStem Technologies Secures Up to $40 Million in a Committed Equity Facility
BioStem Technologies Secures Up to $40 Million in a Committed Equity FacilityBioStem Technologies Opens Hospital Access for VENDAJE® and VENDAJE AC® Through Vizient and Premier
BioStem Technologies Expands Contracts with Two of the Largest Group Purchasing Organizations in the United StatesBioStem Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference
BioStem Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioStem Technologies
Sign Up For FreeTo access detailed company insights
BioStem Technologies, Inc. is a global life sciences corporation, providing innovative technologies with a concentration in Regenerative Medicine. The company's mission is to discover, develop and produce the most effective Regenerative Medicine products in the world. BioStem Technologies offers a comprehensive portfolio of high-quality brands that... Read More
